Mycoplasma synoviae: Infectious Synovitis in Chickens and Turkeys – Eggshell Apex Abnormalities and Control

Introduction

Mycoplasma synoviae is a significant pathogen of commercial poultry worldwide, causing infectious synovitis, respiratory disease, and eggshell apex abnormalities (EAA) in chickens and turkeys. The economic impact of M. synoviae infection arises from reduced egg production, increased mortality, carcass condemnation, and costs associated with treatment and control. The pathogen is classified under the class Mollicutes and is characterized by its small genome, lack of a cell wall, and dependence on host-derived nutrients. This article provides a clinical and molecular review of Mycoplasma synoviae infectious synovitis in chickens and turkeys, with particular emphasis on eggshell apex abnormalities and integrated control approaches.

Etiology and Taxonomy

Mycoplasma synoviae is a member of the family Mycoplasmataceae. It possesses a reduced genome (approximately 800–900 kb) and exhibits a flask-shaped morphology with a terminal tip structure involved in host cell adhesion. The organism lacks a peptidoglycan cell wall, rendering it intrinsically resistant to beta-lactam antimicrobials and dependent on membrane sterols for growth. Several virulence factors have been characterized, including the variable lipoprotein hemagglutinin (VlhA) and its processed products MSPB and MSPA [1, 2]. The VlhA protein mediates hemagglutination and is a major immunogen. The hemagglutination-positive phenotype is associated with a higher frequency of experimental synovitis [2]. Additional virulence-associated proteins include dihydrolipoamide acetyltransferase, which mediates adhesion and invasion of host cells [3], and the conserved membrane antigen P35 [4]. Biofilm formation has been documented in M. synoviae and correlates with reduced antimicrobial susceptibility [5]. Three genes influencing colonization, immunogenicity, and transmissibility were identified by targeted mutagenesis [6].

Epidemiology and Genetic Diversity

Mycoplasma synoviae is distributed globally. Prevalence studies in central China (2021–2023) reported a high frequency of infection, with extensive vlhA gene genotypic diversity [7]. Nationwide multilocus sequence typing (MLST) in China (2024) revealed unique sequence types (STs) and emerging genetic trends [8]. Earlier MLST analyses in China identified STs distinct from those in other regions [9]. In central China from 2017 to 2019, local genotype diversity was detected through vlhA sequencing [10]. Characterization of Thai isolates by vlhA sequence analysis demonstrated distinct phylogenetic clusters [11]. Korean isolates exhibited nicotinamide adenine dinucleotide (NAD) independence and carried genomic alterations compared to reference strains [12]. Native chicken breeds in China harbor pathogenic strains with variable virulence [13]. Transmission investigations in Chinese indigenous chickens confirmed both vertical and horizontal routes [14]. The genetic diversity of M. synoviae has implications for vaccine efficacy and diagnostic assay design.

Clinical Signs and Pathogenesis

In chickens and turkeys, Mycoplasma synoviae infectious synovitis manifests as lameness, swollen joints (hock and wing joints), breast blisters, and reluctance to move. Respiratory signs include rales, sneezing, and airsacculitis, particularly when co-infection with other respiratory pathogens occurs. The onset of eggshell apex abnormalities (EAA) in laying hens is one of the most economically relevant manifestations. EAA is characterized by a roughened, thickened, glassy appearance at the apex of the eggshell, often accompanied by a translucent ring and increased shell fragility. Spectral techniques have been developed to detect changes in eggshells caused by M. synoviae infection [15].

The pathogenesis of infectious synovitis involves colonization of the respiratory mucosa followed by hematogenous dissemination to synovial tissues. Interaction with chicken synovial fibroblasts induces proliferation and upregulation of serum amyloid A [16]. Transcriptomic and proteomic analyses of infected synovial fibroblasts reveal modulation of inflammatory and apoptotic pathways [17]. The tracheal transcriptional response to chronic infection involves changes in immune-related genes [18]. Splenic and tracheal transcriptional profiling after infection with a virulent strain showed differential expression of genes associated with innate immunity [19]. In chicken chondrocytes, M. synoviae infection alters metabolic and sensitivity profiles, including modulation of glycolysis and matrix metalloproteinase activity [20, 21]. The lipoprotein MSPB induces secretion of nitric oxide, interleukin-6 (IL-6), and interleukin-1beta (IL-1beta) in chicken macrophages, contributing to the inflammatory response [1].

Pathology

Gross lesions in infectious synovitis include synovial membranes thickened with fibrinous exudate, joint effusions containing heterophils, and periarticular edema. Chronic cases show caseous exudate in joint spaces. Respiratory lesions include airsacculitis, pneumonitis, and tracheitis. In laying hens, the oviduct may be affected, leading to EAA. Histopathological examination reveals synovial hyperplasia, infiltration of mononuclear cells, and fibrin deposition. Co-infection with other agents, such as Pasteurella gallinarum or Staphylococcus aureus, can exacerbate lesion severity [22, 23]. Dual infection with infectious bursal disease virus enhances synovitis development [24].

Diagnosis

Accurate diagnosis is essential for control. Isolation of M. synoviae in culture is definitive but slow and requires specialized media (e.g., Frey's medium with nicotinamide adenine dinucleotide). The organism grows slowly, producing typical "fried egg" colonies after 3–7 days. Molecular diagnostics have largely supplanted culture for routine detection. Polymerase chain reaction (PCR) targeting the vlhA gene is widely used for species identification and genotyping [7, 11]. The development of a dual-mode recombinase-aided amplification (RAA) combined with CRISPR/Cas12a allows rapid nucleic acid detection with high sensitivity [25]. An insulated isothermal PCR assay on a field-deployable device provides rapid detection suitable for on-farm use [26].

Serological methods include commercial enzyme-linked immunosorbent assay (ELISA) kits and the serum plate agglutination (SPA) test. A novel indirect ELISA based on the LP53 lipoprotein has demonstrated improved specificity [27]. Differentiation of vaccine strains (MS-H and MS1) from field isolates is critical for vaccination programs. Several molecular strategies have been developed: mismatch amplification mutation assays (MAMAs) for MS1 and MS-H differentiation [28], high-resolution melting (HRM) curve analysis targeting genetic markers in MS-H [29], and a rapid cost-effective method for ts+ vaccine strain identification [30]. Comparative genomics of MS-H and its wild-type parent strain 86079/7NS identified mutations useful for diagnostic discrimination [31].

The table below summarizes diagnostic approaches.

Antimicrobial Susceptibility and Treatment

Treatment of Mycoplasma synoviae infectious synovitis relies on antimicrobials active against Mollicutes. Tetracyclines (e.g., chlortetracycline) have historical efficacy [32]. Macrolides, lincosamides, and fluoroquinolones are also used. However, acquired resistance has emerged. Mutations in the 23S rRNA gene (macrolides/lincosamides) and in the DNA gyrase genes (fluoroquinolones) have been associated with decreased susceptibility [33, 34]. Susceptibility profiling of Central and Eastern European strains revealed geographic variation in minimum inhibitory concentrations (MICs) for tylosin, tilmicosin, enrofloxacin, and lincomycin [35]. Biofilm formation correlates with drug resistance, complicating therapy [5]. Antimicrobial susceptibility testing can be performed using broth microdilution methods, and molecular assays for resistance marker detection have been developed [33].

In addition to conventional antibiotics, alternative therapeutic strategies have been investigated. Berberine inhibits M. synoviae infection by suppressing PIK3CA-dependent inflammatory and apoptotic responses in avian macrophages [36]. The botanical compound mixture known as Tengchuan compound reduces synovitis severity through modulation of host metabolism and gut microbiota, as shown by integrated network pharmacology, metabolomics, and 16S rRNA sequencing [37]. These approaches may offer adjunctive or replacement options in the face of antimicrobial resistance.

Control and Prevention

Control strategies for Mycoplasma synoviae infectious synovitis in chickens and turkeys include biosecurity, management practices, vaccination, and eradication programs in breeder flocks. Biosecurity measures must prevent introduction via contaminated equipment, personnel, or live birds. Vertical transmission can be reduced by establishing M. synoviae-free breeder flocks through serological monitoring and culling.

Vaccination is a key tool. The temperature-sensitive live vaccine MS-H (ts+ strain) is widely used in many regions. Methods to differentiate MS-H from field strains facilitate post-vaccination surveillance [31, 29, 30]. Another vaccine strain, MS1, is differentiated using mismatch amplification assays [28]. Inactivated vaccines prepared from local isolates have shown immune protection efficacy in chickens [38]. A multi-component subunit vaccine based on target antigen screening induced protective immunity [39]. The conserved antigen P35 has also been evaluated as a vaccine candidate [4].

The mermaid diagram below illustrates a decision framework for diagnosis, strain differentiation, and control intervention.

flowchart TD
    A[Clinical signs: lameness, EAA, respiratory], > B[Submit samples: swabs, serum, eggs]
    B, > C{Detection method}
    C, > D[PCR / RAA-CRISPR: Positive]
    C, > E[ELISA / SPA: Seropositive]
    D, > F[Determine vlhA genotype / ST]
    F, > G{Compare with vaccine strain}
    G, > H[Match MS-H/MS1?]
    H, >|Yes| I[Vaccine reaction likely]
    H, >|No| J[Field strain confirmed]
    I, > K[Monitor flock, no additional action]
    J, > L[Assess antimicrobial susceptibility]
    L, > M[Choose treatment: tetracyclines, macrolides, or alternatives]
    M, > N[Implement biosecurity, consider vaccination program]
    E, > O[Confirm with molecular testing]
    O, > F

Integrated control programs should consider co-infections with other respiratory pathogens such as Mycoplasma gallisepticum and Ornithobacterium rhinotracheale. The principles of biosecurity and vaccination applied to M. synoviae share common elements with those for Infectious Coryza in Poultry. Management of eggshell apex abnormalities also involves nutritional adjustments to improve shell quality.

Eggshell Apex Abnormalities (EAA)

Eggshell apex abnormalities are a specific clinical manifestation of M. synoviae infection in laying hens. The condition reduces egg quality and hatchability, leading to economic losses. The pathogenesis of EAA involves colonization of the oviduct, particularly the shell gland (uterus), resulting in abnormal calcification at the egg apex. Detection of shell changes can be performed using spectral techniques [15]. Control of EAA requires effective flock-level management of M. synoviae infection, including vaccination and antimicrobial intervention when indicated.

Conclusion

Mycoplasma synoviae remains a challenge to the poultry industry worldwide, causing infectious synovitis, respiratory disease, and eggshell apex abnormalities in chickens and turkeys. Advances in molecular diagnostics, including CRISPR-based detection and vaccine strain differentiation, have improved the ability to detect and control infections. The emergence of antimicrobial resistance underscores the need for prudent antibiotic use and the development of alternative therapies and effective vaccines. Continued surveillance using MLST and vlhA genotyping is essential to monitor genetic diversity and inform control strategies.

References

[1] Lavric M, Bencina D, Kothlow S, et al. Mycoplasma synoviae lipoprotein MSPB, the N-terminal part of VlhA haemagglutinin, induces secretion of nitric oxide, IL-6 and IL-1beta in chicken macrophages. Vet Microbiol. 2007. URL: https://pubmed.ncbi.nlm.nih.gov/17254721/

[2] Narat M, Bencina D, Kleven SH, et al. The hemagglutination-positive phenotype of Mycoplasma synoviae induces experimental infectious synovitis in chickens more frequently than does the hemagglutination-negative phenotype. Infect Immun. 1998. URL: https://pubmed.ncbi.nlm.nih.gov/9826385/

[3] Ma H, Zhao Y, He X, et al. Dihydrolipoamide acetyltransferase is a key factor mediating adhesion and invasion of host cells by Mycoplasma synoviae. Vet Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39561529/

[4] Sun Q, Wei X, Chen W, et al. Characterization and Evaluation of a Novel Conserved Membrane Antigen P35 of Mycoplasma synoviae. Front Vet Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35280133/

[5] Kang T, Zhou M, Yan X, et al. Biofilm formation and correlations with drug resistance in Mycoplasma synoviae. Vet Microbiol. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37267807/

[6] Klose SM, Omotainse OS, Zare S, et al. Virulence factors of Mycoplasma synoviae: Three genes influencing colonization, immunogenicity, and transmissibility. Front Microbiol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36532420/

[7] Zhang W, Deng L, Liu T, et al. Research note: Prevalence and vlhA gene genotyping analysis of Mycoplasma synoviae in poultry from 2021 to 2023 in central China. Poult Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41075596/

[8] Tu L, Li X, Liu Y, et al. Genetic Diversity and Emerging Trends of Mycoplasma synoviae in China: Insights from a 2024 Nationwide MLST Study. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597774/

[9] Zhang X, Chen Y, Xie D, et al. Multi-locus sequence typing analysis of Mycoplasma synoviae isolates reveals unique sequence types in China. Vet Microbiol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34166888/

[10] Sui C, Cui H, Ji J, et al. Epidemiological investigations and locally determined genotype diversity of Mycoplasma synoviae in Central China from 2017 to 2019. Poult Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/34818613/

[11] Limpavithayakul K, Sasipreeyajan J, Pakpinyo S. Characterization of Thai Mycoplasma synoviae Isolates by Sequence Analysis of Partial vlhA Gene. Avian Dis. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27902903/

[12] Song Y, La TM, Kim T, et al. Genome Analysis of Nicotinamide Adenine Dinucleotide-Independent Mycoplasma synoviae Isolates From Korea. Pathogens. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34684178/

[13] Sun S, Lin X, Liu J, et al. Phylogenetic and pathogenic analysis of Mycoplasma Synoviae isolated from native chicken breeds in China. Poult Sci. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28093481/

[14] Yin L, Luo Y, Li C, et al. Transmission investigation of Mycoplasma synoviae in Chinese indigenous chickens. Front Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40433458/

[15] Lorenc Z, Paśko S, Kursa O, et al. Spectral technique for detection of changes in eggshells caused by Mycoplasma synoviae. Poult Sci. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31002107/

[16] Liu R, Xu B, Zhang J, et al. Mycoplasma synoviae induces serum amyloid A upregulation and promotes chicken synovial fibroblast cell proliferation. Microb Pathog. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33727170/

[17] Liu R, Xu B, Yu S, et al. Integrated Transcriptomic and Proteomic Analyses of the Interaction Between Chicken Synovial Fibroblasts and Mycoplasma synoviae. Front Microbiol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32318048/

[18] Kamathewatta KI, Condello AK, Kulappu Arachchige SN, et al. Characterisation of the tracheal transcriptional response of chickens to chronic infection with Mycoplasma synoviae. Vet Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38772075/

[19] Chen W, Sun Q, Yan Z, et al. Transcriptional profiling of the chicken tracheal and splenic response to virulent Mycoplasma synoviae. Poult Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35077920/

[20] Cizelj I, Dušanić D, Benčina D, et al. Mycoplasma and host interaction: In vitro gene expression modulation in Mycoplasma synoviae and infected chicken chondrocytes. Acta Vet Hung. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/26919139/

[21] Dušanić D, Benčina D, Narat M, et al. Phenotypic characterization of Mycoplasma synoviae induced changes in the metabolic and sensitivity profile of in vitro infected chicken chondrocytes. Biomed Res Int. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/25243158/

[22] Droual R, Shivaprasad HL, Meteyer CU, et al. Severe mortality in broiler chickens associated with Mycoplasma synoviae and Pasteurella gallinarum. Avian Dis. 1992. URL: https://pubmed.ncbi.nlm.nih.gov/1417618/

[23] Hinz KH, Lüders H. [Occurrence of infectious synovitis (Mycoplasma synoviae infection) complicated by Staphylococcus aureus in chickens in northern Germany]. Dtsch Tierarztl Wochenschr (1946). 1969. URL: https://pubmed.ncbi.nlm.nih.gov/5813871/

[24] Yagihashi T, Nunoya T, Otaki Y. Effects of dual infection of chickens with Mycoplasma synoviae and Mycoplasma gallinaceum or infectious bursal disease virus on infectious synovitis. Nihon Juigaku Zasshi. 1983. URL: https://pubmed.ncbi.nlm.nih.gov/6314027/

[25] Hu Q, Liu J, Zhang W, et al. Rapid nucleic acid detection of Mycoplasma synoviae using dual-mode RAA-CRISPR/Cas12a system. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41270550/

[26] Kuo HC, Lo DY, Chen CL, et al. Rapid and sensitive detection of Mycoplasma synoviae by an insulated isothermal polymerase chain reaction-based assay on a field-deployable device. Poult Sci. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/27389062/

[27] Li H, Hu Z, Wang G, et al. Development of an indirect ELISA based on a new specific lipoprotein LP53 for the detection of antibodies against Mycoplasma synoviae. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40450297/

[28] Kreizinger Z, Sulyok KM, Grózner D, et al. Development of mismatch amplification mutation assays for the differentiation of MS1 vaccine strain from wild-type Mycoplasma synoviae and MS-H vaccine strains. PLoS One. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28419134/

[29] Zhu L, Konsak BM, Olaogun OM, et al. Identification of a new genetic marker in Mycoplasma synoviae vaccine strain MS-H and development of a strategy using polymerase chain reaction and high-resolution melting curve analysis for differentiating MS-H from field strains. Vet Microbiol. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/29103696/

[30] Kreizinger Z, Sulyok KM, Pásztor A, et al. Rapid, Simple and Cost-Effective Molecular Method to Differentiate the Temperature Sensitive (ts+) MS-H Vaccine Strain and Wild-Type Mycoplasma synoviae Isolates. PLoS One. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/26207635/

[31] Zhu L, Shahid MA, Markham J, et al. Comparative genomic analyses of Mycoplasma synoviae vaccine strain MS-H and its wild-type parent strain 86079/7NS: implications for the identification of virulence factors and applications in diagnosis of M. synoviae. Avian Pathol. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31244324/

[32] Olson NO, Sahu SP. Efficacy of chlortetracycline against Mycoplasma synoviae isolated in two periods. Avian Dis. 1976. URL: https://pubmed.ncbi.nlm.nih.gov/938371/

[33] Bekő K, Kreizinger Z, Yvon C, et al. Development of molecular assays for the rapid and cost-effective determination of fluoroquinolone, macrolide and lincosamide susceptibility of Mycoplasma synoviae isolates. PLoS One. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33125410/

[34] Bekő K, Kreizinger Z, Kovács ÁB, et al. Mutations potentially associated with decreased susceptibility to fluoroquinolones, macrolides and lincomycin in Mycoplasma synoviae. Vet Microbiol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32891024/

[35] Kreizinger Z, Grózner D, Sulyok KM, et al. Antibiotic susceptibility profiles of Mycoplasma synoviae strains originating from Central and Eastern Europe. BMC Vet Res. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/29149886/

[36] Sun Y, Hu W, Li S, et al. Berberine inhibits Mycoplasma synoviae infection by suppressing PIK3CA-dependent inflammatory and apoptotic responses in avian macrophages. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41115537/

[37] Kan Q, Luo J, Zhao L, et al. Tengchuan compound mixture ameliorates Mycoplasma Synoviae-induced synovitis: An integrated network pharmacology, metabolomics, and 16S rRNA sequencing study. Poult Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41072088/

[38] Wang Z, Chen L, Song L, et al. Isolation and identification of Mycoplasma synoviae in Hebei, China, and evaluation of the immune protection efficacy of inactivated vaccines. Poult Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40592287/

[39] Sun X, Deng M, Cheng C, et al. Target antigen screening and development of a multi-component subunit vaccine against Mycoplasma synoviae in chickens. Front Cell Infect Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39507944/

[40] Yadav JP, Tomar P, Singh Y, et al. Insights on Mycoplasma gallisepticum and Mycoplasma synoviae infection in poultry: a systematic review. Anim Biotechnol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/33840372/

[41] Rebollo Couto MS, Klein CS, Voss-Rech D, et al. Extracellular Proteins of Mycoplasma synoviae. ISRN Vet Sci. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/23762591/

[42] Barbour EK, Hamadeh SK, Hilan C, et al. National surveillance of poultry diseases in Lebanon. Rev Sci Tech. 1997. URL: https://pubmed.ncbi.nlm.nih.gov/9567302/

[43] Stipkovits L, Kempf I. Mycoplasmoses in poultry. Rev Sci Tech. 1996. URL: https://pubmed.ncbi.nlm.nih.gov/9190023/

[44] Morrow CJ, Bell IG, Walker SB, et al. Isolation of Mycoplasma synoviae from infectious synovitis of chickens. Aust Vet J. 1990. URL: https://pubmed.ncbi.nlm.nih.gov/2375719/

[45] Buys SB. The isolation of Mycoplasms synoviae from chickens with infectious synovitis and air-sacculitis in the Republic of South Africa. Onderstepoort J Vet Res. 1976. URL: https://pubmed.ncbi.nlm.nih.gov/1018888/

[46] Kleven SH, Fletcher OJ, Davis RB. Influence of strain of Mycoplasma synoviae and route of infection on development of synovitis or airsacculitis in broilers. Avian Dis. 1975. URL: https://pubmed.ncbi.nlm.nih.gov/1120029/

[47] Goren E. [Preliminary studies on the aetiology of infectious synovitis in chickens in the Netherlands, with special reference to the role of Mycoplasma synoviae (author's transl)]. Tijdschr Diergeneeskd. 1973. URL: https://pubmed.ncbi.nlm.nih.gov/4792031/

[48] Hinz KH, Lüders H. [Occurrence of infectious synovitis (Mycoplasma synoviae infection) complicated by Staphylococcus aureus in chickens in North Germany]. Dtsch Tierarztl Wochenschr (1946). 1969. URL: https://pubmed.ncbi.nlm.nih.gov/5813306/